EAM
KRYS icon

Eventide Asset Management’s Krystal Biotech KRYS Stock Holding History

Eventide Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95,781
Closed -$17.3M – 245
2025
Q1 		$17.3M Hold
95,781
– – 0.34% 95
2024
Q4 		$15M Hold
95,781
– – 0.27% 112
2024
Q3 		$17.4M Sell
95,781
-40,704
-30% -$7.85M 0.3% 97
2024
Q2 		$25.1M Hold
136,485
– – 0.43% 76
2024
Q1 		$24.3M Hold
136,485
– – 0.38% 81
2023
Q4 		$16.9M Buy
+136,485
New +$15.1M 0.28% 95

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return